peter md semaglutide reviews Gpl1 Peter MD Reviews and Effectiveness

2025;44(1):200

Semaglutide: Tirzepatide is a dual agonist for GLP-1 and GIP receptors

GLP-1, barsaklarmz tarafndan salglanan bir inkretin hormonudur

As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be safe or effective

Semaglutide patent expiry in mid-March 2026 set to trigger entry of 50+ branded generics in India: Sheetal Sapale

The net benefit of GLP-1 receptor agonists in adults with overweight or obesity who do not have diabetes depends on their weight loss target and willingness to accept harms, according to researchers.Although GLP-1 receptor agonists have demonstrated effectiveness in reducing weight loss and risks for other chronic diseases, questions remain over whether the benefits outweigh the harms of the